نتایج جستجو برای: triple negative breast neoplasms

تعداد نتایج: 1173968  

2013
Stina Mui Singel Crystal Cornelius Kimberly Batten Gail Fasciani Woodring E. Wright Jerry W. Shay

Purpose: To identify biomarkers within the breast cancer genome that may predict chemosensitivity in

2015
Zining Jin Wenqian Wang Nan Jiang Lei Zhang Yiming Li Xiaoyin Xu Shouliang Cai Liang Wei Xuhong Liu Guanglei Chen Yizhen Zhou Cheng Liu Zhan Li Feng Jin Bo Chen Ying-Jan Wang

Triple-negative breast cancer is a high-risk breast cancer with poor survival rate. To date, there is a lack of targeted therapy for this type of cancer. One unique phenomenon is that inflammatory breast cancer is frequently triple negative. However, it is still ambiguous how inflammation influences triple-negative breast cancer growth and responding to chemotherapy. Herein, we investigated the...

Journal: :The American Journal of Pathology 2017

2009
Jessica M. Dolle Janet R. Daling Emily White Louise A. Brinton David R. Doody Peggy L. Porter Kathleen E. Malone

Little is known about the etiologic profile of triplenegative breast cancer (negative for estrogen receptor/ progesterone receptor/human epidermal growth factor), a breast cancer subtype associated with high mortality and inadequate therapeutic options. We undertook this study to assess the risk for triple-negative breast cancer among women 45 years of age and younger in relation to demographic...

Journal: :American Journal of Clinical Pathology 2014

Journal: :Molecular cancer therapeutics 2011
Tongrui Liu Rami Yacoub LaTonia D Taliaferro-Smith Shi-Yong Sun Tisheeka R Graham Ryan Dolan Christine Lobo Mourad Tighiouart Lily Yang Amy Adams Ruth M O'Regan

Triple-negative breast cancers, which lack estrogen receptor, progesterone receptor, and HER2/neu overexpression, account for approximately 15% of breast cancers, but occur more commonly in African Americans. The poor survival outcomes seen with triple-negative breast cancers patients are, in part, due to a lack of therapeutic targets. Epidermal growth factor receptor (EGFR) is overexpressed in...

2009
Carmelo Bengala

Triple-negative breast cancer (TNBC) has been recently recognized as an important subgroup of breast cancer with a distinct outcome and therapeutic approach compared with other breast cancer subgroups. Because TNBC is defined by the absence of a target (either hormone receptors or HER-2), conventional cytotoxic therapy is still the mainstay of treatment. This report focuses on the current state...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2015
Steven A Narod Rebecca A Dent William D Foulkes

The research article by Dent and colleagues, which was published in the August 1, 2007, issue of Clinical Cancer Research, provided a clinical description of metastatic progression of triple-negative breast cancers. Finding successful treatment strategies for women with triple-negative breast cancer remains a challenge.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید